Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

novartis_outside_1

EU approval for Novartis’ Cosentyx in active non-radiographic axial spondyloarthritis

April 29, 2020 Research and Development, Sales and Marketing Cosentyx, EU, Novartis, axial spondyloarthritis, pharma

Novartis has revealed that the European Commission has moved to approve Cosentyx (secukinumab) for the treatment of active non-radiographic axial …
News
pharmafocus_may_2020_cover

The May 2020 issue of Pharmafocus is available to read free online now!

April 28, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

The latest monthly edition of Pharmafocus, the May 2020 issue, is available to read for free online now!
News

Reinventing the value equation

April 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, feature, real world data, real world evidence, real-world data, real-world evidence

There is a duty to ensure access to innovative treatments for patients with unmet need, but a health service gatekeeper …
Feature

Sanofi’s Meningococcal Conjugate Vaccine secures FDA approval in patients aged two and up

April 27, 2020 Sales and Marketing FDA, MenQuadfi, Sanofi, US, meningococcal disease, pharma

Sanofi’s MedQuadfi Meningococcal Conjugate Vaccine has scored FDA approval for the prevention of invasive meningococcal disease, becoming the first and …
News
italy_lockdown

Italy to relax COVID-19 lockdown in early May

April 27, 2020 Sales and Marketing COVID-19, COVID-19 coronavirus, Italy, coronavirus

Italy has outlined its plans to ease the lockdown restrictions that were implemented across the country 7 weeks ago to …
News
researchers

Researchers studying heartburn drug as potential coronavirus treatment

April 27, 2020 Sales and Marketing COVID-19, Pepcid, coronavirus, pandemic

Researchers in America have been studying famotidine, the active ingredient in Pepcid, as a potential treatment for COVID-19. Pepcid is …
News
hazmat

‘Excess deaths’ in England among the highest in Europe

April 27, 2020 Sales and Marketing COVID-19, coronavirus, deaths, pandemic

English excess deaths from the coronavirus are comparable to the worst hit countries in Europe, according to a Sky News …
News
images_1

FDA urges close monitoring of COVID-19 patients treated with hydroxychloroquine

April 27, 2020 Sales and Marketing COVID-19, FDA, chloroquine, coronavirus, hydroxychloroquine

The FDA has released a safety communication reiterating the need for doctors to closely monitor COVID-19 patients who are treated …
News
aloe-vera-2417091_960_720

European Medicines Agency’s review of Picato finds its risks outweigh its benefits

April 24, 2020 Business Services, Medical Communications, Sales and Marketing

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that the risks from using Picato are too high …
News

FDA approves Immunomedics’ Trodelvy for metastatic triple-negative breast cancer one month ahead of schedule

April 23, 2020 Sales and Marketing Cancer, Immunomedics, Trodelvy, breast cancer, pharma

Immunomedics has scored approval with the FDA for Trodelvy (sacituzumab govitecan-hziy) in the treatment of metastatic triple-negative breast cancer, it …
News
boehringer_biberach_germany_copy

Boehringer’s nintedanib approved in Europe for systemic sclerosis-associated interstitial lung disease

April 22, 2020 Research and Development, Sales and Marketing Boehringer Ingelheim, EU, nintedanib, pharma

The European Commission has moved to authorise Boehringer Ingelheim’s nintedanib in Europe for the treatment of systemic sclerosis-associated interstitial lung …
News
abbvie_0

AbbVie’s Imbruvica scoops up 11th FDA approval with chronic lymphocytic leukaemia/small lymphocytic lymphoma nod

April 22, 2020 Research and Development, Sales and Marketing Cancer, FDA, imbruvica, leukaemia

AbbVie’s Imbruvica (ibrutinib) has scored its 11th FDA approval, this time in combination with rituximab for the treatment of chronic …
News

Bayer’s Vitrakvi becomes first tumour-agnostic therapy approved by NICE for NHS patients with NTRK fusion+ cancer

April 21, 2020 Manufacturing and Production, Sales and Marketing Bayer, Cancer, NICE, UK, Vitrakvi, tumour agnostic

Bayer’s oral TRK inhibitor Vitrakvi (larotrectinib) has just been recommended by NICE in the treatment of advanced neurotrophic tyrosine receptor …
News
ny

How the intended role of generic medicines is being undermined in America

April 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, US, feature, generic medicines, generics

The introduction of a generic medicine should, in theory, incentivise companies to lower the price of the original drug, creating healthy …
Feature
real_testing

Novartis to sponsor large clinical trial of hydroxychloroquine in COVID-19 patients

April 20, 2020 Sales and Marketing COVID19 Coronavirus, coronavirus, covid19

The FDA and Novartis have agreed to move forward with a Phase 3 clinical trial to evaluate the effectiveness of …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025